Hohimer Wealth Management, LLC Bausch Health Companies Inc. Transaction History

Hohimer Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$7.06 - $23.63 $96,227 - $322,076	-13,630 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$21.6 - $27.79 $86,400 - $111,160	4,000 Added 41.54%	13,630 $311,000
Q4 2021 Jan 25, 2022	SELL	$23.0 - $29.01 $12,052 - $15,201	-524 Reduced 5.16%	9,630 $266,000
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $151,091 - $204,400	10,154 New	10,154 $175,000
Q1 2020 May 05, 2020	SELL	$12.98 - $30.25 $209,899 - $489,172	-16,171 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $305,470 - $515,693	16,171 New	16,171 $484,000

272

280M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hohimer Wealth Management, LLC with notifications on news.